Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
6.30
-0.17 (-2.63%)
Sep 4, 2026, 12:59 PM EDT - Market open
Teladoc Health Revenue
Teladoc Health had revenue of $606.93M in the quarter ending June 30, 2026, a decrease of -3.95%. This brings the company's revenue in the last twelve months to $2.49B, down -4.59% year-over-year. In the year 2025, Teladoc Health had annual revenue of $2.53B, down -1.54%.
Revenue (ttm)
$2.49B
Revenue Growth
-4.59%
P/S Ratio
0.46
Revenue / Employee
$444,550
Employees
5,600
Market Cap
1.14B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | -39.60M | -1.54% |
| Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
| Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
| Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
| Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
| Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
| Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
| Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
| Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
| Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
| Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
| Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
| Dec 31, 2013 | 19.91M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Privia Health Group | 2.36B |
| Omnicell | 1.25B |
| Claritev | 994.67M |
| GoodRx Holdings | 785.23M |
| Phreesia | 507.79M |
| Certara | 421.75M |
| HealthStream | 321.12M |
| Omada Health | 309.76M |
TDOC News
- 20 hours ago - Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 - GlobeNewsWire
- 4 days ago - Teladoc appoints insurance executive Michael Grasher as CFO - Reuters
- 4 days ago - Teladoc appoints Michael Grasher as CFO - TheFly
- 4 days ago - Teladoc Health Appoints Michael Grasher as Chief Financial Officer - GlobeNewsWire
- 18 days ago - Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 4 weeks ago - Teladoc put volume heavy and directionally bearish - TheFly
- 4 weeks ago - Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors - GlobeNewsWire
- 4 weeks ago - Teladoc price target lowered to $7.50 from $11 at Citi - TheFly